Literature DB >> 35113300

Affect regulation as a moderator of intentions for breast cancer chemoprevention.

Claire C Conley1,2, Doreen M Agnese3, Susan T Vadaparampil4, Suzanne C O'Neill5, Barbara L Andersen3.   

Abstract

Women at high risk for breast cancer (BC) may consider chemoprevention for risk reduction, but uptake is low. This study examined the role of affect regulation (the attempt to alter or control one's emotions) in decision-making about BC chemoprevention. A cross-sectional, single group design was used. High-risk women (N = 81) were surveyed. Moderation analyses specified cancer-specific distress as the independent variable, affect regulation (cognitive reappraisal or expressive suppression) as the moderator, and chemoprevention intentions (yes = 1, unsure = 0, no = -1) as the dependent variable. Cognitive reappraisal significantly moderated the relationship between cancer-specific distress and chemoprevention intentions (p = 0.03), but expressive suppression did not (p = 0.31). For the 44% of participants who were highest on reappraisal, higher cancer-specific distress was associated with greater intentions for chemoprevention. For the remaining 56%, there was no relationship between cancer-specific distress and chemoprevention intentions. Cognitive reappraisal may play an important role in decisions regarding uptake of chemoprevention.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Affect regulation; Breast cancer; Chemoprevention; Decision making; Risk management

Mesh:

Year:  2022        PMID: 35113300      PMCID: PMC9167227          DOI: 10.1007/s10865-022-00289-3

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  30 in total

Review 1.  Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis.

Authors:  Mary E Ropka; Jess Keim; John T Philbrick
Journal:  J Clin Oncol       Date:  2010-05-10       Impact factor: 44.544

2.  Emotion regulation choice: a conceptual framework and supporting evidence.

Authors:  Gal Sheppes; Susanne Scheibe; Gaurav Suri; Peter Radu; Jens Blechert; James J Gross
Journal:  J Exp Psychol Gen       Date:  2012-11-19

3.  Emotional control and autonomic arousal in breast cancer patients.

Authors:  M Watson; K W Pettingale; S Greer
Journal:  J Psychosom Res       Date:  1984       Impact factor: 3.006

4.  The importance of communication in collaborative decision making: facilitating shared mind and the management of uncertainty.

Authors:  Mary C Politi; Richard L Street
Journal:  J Eval Clin Pract       Date:  2010-09-12       Impact factor: 2.431

5.  Participation in randomised clinical trials is linked to emotion regulation strategies.

Authors:  Tanguy Leroy; Véronique Christophe; Nicolas Penel; Stéphanie Clisant; Pascal Antoine
Journal:  Contemp Clin Trials       Date:  2010-09-15       Impact factor: 2.226

6.  The Affect Regulation in Cancer framework: Understanding affective responding across the cancer trajectory.

Authors:  Maria Kangas; James J Gross
Journal:  J Health Psychol       Date:  2017-12-20

7.  Affective science perspectives on cancer control: strategically crafting a mutually beneficial research agenda.

Authors:  Rebecca A Ferrer; Paige A Green; Lisa Feldman Barrett
Journal:  Perspect Psychol Sci       Date:  2015-05

Review 8.  The role of cancer worry in cancer screening: a theoretical and empirical review of the literature.

Authors:  Jennifer L Hay; Tamara R Buckley; Jamie S Ostroff
Journal:  Psychooncology       Date:  2005-07       Impact factor: 3.894

9.  Breast cancer anxiety's associations with responses to a chemoprevention decision aid.

Authors:  Amanda J Dillard; Laura Scherer; Peter A Ubel; Dylan M Smith; Brian J Zikmund-Fisher; Jennifer B McClure; Sarah Greene; Azadeh Stark; Angela Fagerlin
Journal:  Soc Sci Med       Date:  2012-11-02       Impact factor: 4.634

10.  When does risk perception predict protection motivation for health threats? A person-by-situation analysis.

Authors:  Rebecca A Ferrer; William M P Klein; Aya Avishai; Katelyn Jones; Megan Villegas; Paschal Sheeran
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.